FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912200047> ?p ?o ?g. }

• W2912200047 endingPage "e416" @default.
• W2912200047 startingPage "e408" @default.
• W2912200047 abstract "A recent study found that the incidence of melanoma and melanoma-related mortality was decreasing in residents of the New England region. However, it is unknown whether this trend is conserved in Veterans of New England who constitute more than 14% of the national Veteran population. Given this, our goal was to analyze the incidence of melanoma in patients of Veteran Integrated Service Network-1 (VISN-1) (geographically consisting of VA health care facilities in Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont) and to calculate an incidence rate ratio (IRR) of melanoma in VISN-1 compared to the general population. Additional goals were to ascertain the risk/susceptibility of this patient population with a view to improve quality of care and outcomes. Data for 523 cases of melanoma [2000–2011] were obtained from the regional branch of the Veterans Affairs Central Cancer Registry (VACCR) within the geographic area comprising VISN-1. A detailed retrospective chart review was conducted on these cases to gather demographic, risk factor, and clinical practice data. Demographic and incidence data from VISN-1 were compared to the general population via data from Surveillance, Epidemiology and End Results Program (SEER) from the same time period. Person-years (PY) were calculated for both populations to measure IRRs which was further standardized for age and gender. VISN-1 patients were predominantly older (94.26% >50 years), Caucasian (99.43%) males (96.75%). Compared to the general population, VISN-1 patients experienced more invasive lesions defined as stage T1 or greater (4.33% vs. 57.12%, p < 0.001), but reduced melanoma-associated mortality (40.96% vs. 19.05%, p < 0.001) although all-cause mortality was approximately doubled (52.20% vs. 26.14%, p < 0.001). Metastatic disease-rates were similar in both [approximately 4% in both]. IRR of melanoma in VISN-1 patients was 0.36 (95% CI: 0.20–0.67; p = 0.0063) which persisted in all age groups/genders. 60.92% of VISN-1 patients had recreational sun-exposure history and 72.41% of tobacco use. 95.02% of melanomas were located in continuously/intermittently sun-exposed areas, 93.28% were surgically-treated with a median treatment delay of 31 days [range 18–48]. Median lost to follow-up was 0 day [range 0–681 days]. Compared to the general population, melanoma incidence was lower in the VISN-1 cohort, possibly due to decreased UV index in the New England region, protective effects of past tobacco use, improved access to care through the VA and regional public health educational efforts. Yet melanomas were more often invasive in the VISN-1 cohort due to advanced age and male sex both of which are associated with more advanced disease at diagnosis. A strength of this study is the calculation of IRR using PY as this method enhances accuracy of incidence calculations. The data were limited by the fact that the population was from one geographic region and consisted mainly of elderly Caucasian males. Descriptive variable data such as sun-protective habits and risk factors from military service are limited by potential recall bias given the retrospective study design. Further study is necessary to replicate these results and to compare our data to Veteran populations from different geographic regions within the USA." @default.
• W2912200047 created "2019-02-21" @default.
• W2912200047 creator A5014118502 @default.
• W2912200047 creator A5020516096 @default.
• W2912200047 creator A5024432811 @default.
• W2912200047 creator A5079631407 @default.
• W2912200047 date "2018-11-05" @default.
• W2912200047 modified "2023-10-13" @default.
• W2912200047 title "Demographics, Risk Factors, and Incidence of Melanoma in Patients in the New England VA Healthcare system" @default.
• W2912200047 cites W112580149 @default.
• W2912200047 cites W1728274462 @default.
• W2912200047 cites W1925000895 @default.
• W2912200047 cites W1932757429 @default.
• W2912200047 cites W1983014406 @default.
• W2912200047 cites W1999932004 @default.
• W2912200047 cites W2021436211 @default.
• W2912200047 cites W2027992128 @default.
• W2912200047 cites W2028071743 @default.
• W2912200047 cites W2031694904 @default.
• W2912200047 cites W2092382625 @default.
• W2912200047 cites W2106005668 @default.
• W2912200047 cites W2109997465 @default.
• W2912200047 cites W2111078144 @default.
• W2912200047 cites W2113865676 @default.
• W2912200047 cites W2121962845 @default.
• W2912200047 cites W2126688900 @default.
• W2912200047 cites W2128163550 @default.
• W2912200047 cites W2131467528 @default.
• W2912200047 cites W2142919660 @default.
• W2912200047 cites W2144124256 @default.
• W2912200047 cites W2147183101 @default.
• W2912200047 cites W2154683287 @default.
• W2912200047 cites W2167242528 @default.
• W2912200047 cites W2317499042 @default.
• W2912200047 cites W2461477619 @default.
• W2912200047 cites W2463902308 @default.
• W2912200047 cites W2538291664 @default.
• W2912200047 cites W2541656092 @default.
• W2912200047 cites W2566509387 @default.
• W2912200047 cites W2566733448 @default.
• W2912200047 cites W2581608312 @default.
• W2912200047 cites W2730542268 @default.
• W2912200047 cites W2777137077 @default.
• W2912200047 cites W2782342304 @default.
• W2912200047 cites W767641944 @default.
• W2912200047 doi "https://doi.org/10.1093/milmed/usy267" @default.
• W2912200047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30395278" @default.
• W2912200047 hasPublicationYear "2018" @default.
• W2912200047 type Work @default.
• W2912200047 sameAs 2912200047 @default.
• W2912200047 citedByCount "6" @default.
• W2912200047 countsByYear W29122000472020 @default.
• W2912200047 countsByYear W29122000472021 @default.
• W2912200047 countsByYear W29122000472022 @default.
• W2912200047 countsByYear W29122000472023 @default.
• W2912200047 crossrefType "journal-article" @default.
• W2912200047 hasAuthorship W2912200047A5014118502 @default.
• W2912200047 hasAuthorship W2912200047A5020516096 @default.
• W2912200047 hasAuthorship W2912200047A5024432811 @default.
• W2912200047 hasAuthorship W2912200047A5079631407 @default.
• W2912200047 hasBestOaLocation W29122000471 @default.
• W2912200047 hasConcept C107130276 @default.
• W2912200047 hasConcept C120665830 @default.
• W2912200047 hasConcept C121332964 @default.
• W2912200047 hasConcept C126322002 @default.
• W2912200047 hasConcept C141071460 @default.
• W2912200047 hasConcept C144024400 @default.
• W2912200047 hasConcept C149923435 @default.
• W2912200047 hasConcept C160735492 @default.
• W2912200047 hasConcept C162324750 @default.
• W2912200047 hasConcept C167135981 @default.
• W2912200047 hasConcept C194828623 @default.
• W2912200047 hasConcept C2775969662 @default.
• W2912200047 hasConcept C2778527826 @default.
• W2912200047 hasConcept C2908647359 @default.
• W2912200047 hasConcept C50522688 @default.
• W2912200047 hasConcept C512399662 @default.
• W2912200047 hasConcept C61511704 @default.
• W2912200047 hasConcept C71924100 @default.
• W2912200047 hasConcept C99454951 @default.
• W2912200047 hasConceptScore W2912200047C107130276 @default.
• W2912200047 hasConceptScore W2912200047C120665830 @default.
• W2912200047 hasConceptScore W2912200047C121332964 @default.
• W2912200047 hasConceptScore W2912200047C126322002 @default.
• W2912200047 hasConceptScore W2912200047C141071460 @default.
• W2912200047 hasConceptScore W2912200047C144024400 @default.
• W2912200047 hasConceptScore W2912200047C149923435 @default.
• W2912200047 hasConceptScore W2912200047C160735492 @default.
• W2912200047 hasConceptScore W2912200047C162324750 @default.
• W2912200047 hasConceptScore W2912200047C167135981 @default.
• W2912200047 hasConceptScore W2912200047C194828623 @default.
• W2912200047 hasConceptScore W2912200047C2775969662 @default.
• W2912200047 hasConceptScore W2912200047C2778527826 @default.
• W2912200047 hasConceptScore W2912200047C2908647359 @default.
• W2912200047 hasConceptScore W2912200047C50522688 @default.
• W2912200047 hasConceptScore W2912200047C512399662 @default.
• W2912200047 hasConceptScore W2912200047C61511704 @default.
• W2912200047 hasConceptScore W2912200047C71924100 @default.

• next